Galapagos NV
GLPG
#4611
Rank
โ‚น188.49 B
Marketcap
โ‚น2,860
Share price
-0.50%
Change (1 day)
25.35%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.53 Billion, an increase over its 2023 earnings that were of -โ‚น3.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8751.57%
2024 -โ‚น0.53 Billion-82.77%
2023 -โ‚น3.05 Billion-85.59%
2022 -โ‚น21.13 Billion60.71%
2021 -โ‚น13.15 Billion-60.08%
2020 -โ‚น32.93 Billion-331.44%
2019 โ‚น14.22 B-523.76%
2018 -โ‚น3.36 Billion-72.34%
2017 -โ‚น12.14 Billion-329.59%
2016 โ‚น5.28 B-144.3%
2015 -โ‚น11.94 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
โ‚น1.187 T-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น2.938 T-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น825.58 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น150.59 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น8.07 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น738.28 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น160.75 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น845.78 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.094 T-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA